The landscape of dementia diagnosis has progressed significantly with the advent of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology many years prior to indicators emerge. When these technological advancements signify extraordinary development in knowing neurodegenerative ailments, they have not https://nicholasb086yju6.wikicarrier.com/user